Cholangiocarcinoma With IDH1 Mutation
1 clinical trials · Condition
◉ Watch Cholangiocarcinoma With IDH1 Mutation
| Record | Firm | Date |
|---|---|---|
| IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor (NCT05814536) | AnHeart Therapeutics Inc. | 2023-05-06 |
Track Cholangiocarcinoma With IDH1 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.